Skip to content
Research Article Open access CC BY 4.0

Chyavanprash: A Multimodal Approach to COVID-19 Management

N. Deepak Venkataraman, R. Meenakshi Sundaram, S. S. Somanathan, T. Purushoth Prabhu, K. P. Rama, S. Jeya Shanmuga Priya

International Journal of Pathogen Research · pp. 12–18 · Published 8 Sep 2021

10.9734/ijpr/2021/v8i130193

Abstract

The word Chyavanprash (CP) comprises of ‘Chyawan’ and ‘Prasha’. Chyavan represents ‘degenerative change’ and Prasha symbolises a drug. Enhancement of immunity and longevity of life were the main reasons for which CP was consumed since ancient times. CP has about 50 herbs, spices and minerals along with a range of pharmacological activities on almost all organ systems of the human body. COVID-19 actually means coronavirus disease 2019. COVID-19 targets and affects multiple organs like lungs, heart, kidney etc, thus increasing the mortality and morbidity rates. The medication cost and side effects have made the allopathic system of medicine the least sought after. The rapid spread rate of the infection has urged mankind to look at alternative remedies to fight the novel coronavirus. AYUSH is a government organisation under the Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy which aims to promote indigenous alternative medicine systems in India. AYUSH recommends various measures to fight the novel coronavirus infection. Chyavanprash is one such important formulation proposed by the AYUSH for COVID-19. The purpose of our review is to highlight the constituents and pharmacological activities of CP in the prophylaxis, manage and treatment of COVID-19 by collecting and compiling the published research on COVID-19. The review also focuses on understanding the mechanism behind the multimodal activity of CP. References relevant to our topic were screened based on relevance to our topic.

Chyavanprash COVID-19 AYUSH alternative medicine systems coronavirus coronaviruses

References (16)

  1. 1 Oxidative stress, inflammation, and cancer: How are they linked? [DOI]
  2. 2 COVID-19 and the cardiovascular system [DOI]
  3. 3 Coronavirus Disease 2019–COVID-19 [DOI]
  4. 4 Antioxidant approach to disease management and the role of ‘Rasayana’ herbs of Ayurveda [DOI]
  5. 5 Public Health Approach of Ayurveda and Yoga for COVID-19 Prophylaxis [DOI]
  6. 6 Chyawanprash: A Traditional Indian Bioactive Health Supplement [DOI]
  7. 7 Characterizing the antioxidant activity of amla (Phyllanthus emblica) extract
  8. 8 Effect of bioactive tannoid principles of Emblica officinalis on ischemia-reperfusion-induced oxidative stress in rat heart [DOI]
  9. 9 The Ayurvedic medicines Haritaki, Amla and Bahira reduce cholesterol-induced atherosclerosis in rabbits [DOI]
  10. 10 Classical uses of Medicinal Plants [DOI]
  11. 11 Scientific Basis for Ayurvedic Therapies [DOI]
  12. 12 Adjunct therapy of Ayurvedic medicine with anti tubercular drugs on the therapeutic management of pulmonary tuberculosis [DOI]
  13. 13 A systematic review on the cardiovascular pharmacology of Emblica officinalis Gaertn. [DOI]
  14. 14 Effect of Chyawanprash and vitamin C on glucose tolerance and lipoprotein profile.
  15. 15 Effect of Sonachandi Chyawanprash and Chyawanprash Plus--two herbal formulations on immunomodulation.
  16. 16 COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? [DOI]

Cited by 3

Showing 2 of 3 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

5

Page views

0

PDF downloads

1

Outbound clicks

3

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.